T&Brothers Capital

T&Brothers Capital operates as a venture capital and asset management firm based in China, focused on the healthcare sector. The firm invests in innovative companies developing advanced medical technologies and solutions. Its strategic approach targets enterprises within life sciences, particularly in precision medicine and diagnostics, providing capital to accelerate market impact.

Established from the insight that specialized investment is critical for evolving healthcare, T&Brothers Capital connects promising innovations with necessary capital. Its inception reflects a commitment to fostering development within the Asian healthcare market. Partner Shu Weilin plays a key role guiding the firm's strategic investments.

T&Brothers Capital primarily serves early to growth-stage healthcare companies seeking strategic funding and operational support. The firm envisions a future where groundbreaking medical technologies and therapeutic approaches are widely accessible, improving global patient outcomes. Through its investments, T&Brothers Capital aims to advance the next generation of healthcare innovations.